Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Net Income (2016 - 2025)

Bio Key International's Net Income history spans 16 years, with the latest figure at -$964849.0 for Q3 2025.

  • For Q3 2025, Net Income fell 30.57% year-over-year to -$964849.0; the TTM value through Sep 2025 reached -$4.3 million, up 19.58%, while the annual FY2024 figure was -$4.3 million, 49.53% up from the prior year.
  • Net Income for Q3 2025 was -$964849.0 at Bio Key International, up from -$1.2 million in the prior quarter.
  • Across five years, Net Income topped out at -$48336.0 in Q2 2021 and bottomed at -$5.0 million in Q4 2022.
  • The 5-year median for Net Income is -$1.4 million (2024), against an average of -$1.6 million.
  • The largest annual shift saw Net Income surged 93.49% in 2021 before it plummeted 3456.27% in 2022.
  • A 5-year view of Net Income shows it stood at -$2.0 million in 2021, then plummeted by 147.03% to -$5.0 million in 2022, then soared by 52.38% to -$2.4 million in 2023, then soared by 41.65% to -$1.4 million in 2024, then skyrocketed by 30.31% to -$964849.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Net Income are -$964849.0 (Q3 2025), -$1.2 million (Q2 2025), and -$736545.0 (Q1 2025).